HL-500

N/A

Report date: 2024/04/25 17:51:35

Base Information

Drug NameHL-500
Drug Alias NameHL500HL-500
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 modulators
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Highlightll Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Highlightll Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A